<mets:mets OBJID="eprint_3486" LABEL="Eprints Item" xsi:schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mets="http://www.loc.gov/METS/" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mets:metsHdr CREATEDATE="2026-07-23T16:22:38Z"><mets:agent ROLE="CUSTODIAN" TYPE="ORGANIZATION"><mets:name>open</mets:name></mets:agent></mets:metsHdr><mets:dmdSec ID="DMD_eprint_3486_mods"><mets:mdWrap MDTYPE="MODS"><mets:xmlData><mods:titleInfo><mods:title>Efficient bioprocess for high-density fermentation and rapid purification of soluble tag-free CRM197 protein expressed in Escherichia coli</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Shubham</mods:namePart><mods:namePart type="family">Singh</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Jaideep</mods:namePart><mods:namePart type="family">Mehta</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Ravi P N</mods:namePart><mods:namePart type="family">Mishra</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Cross-reacting material 197, or CRM197, is a genetically detoxified variant of diphtheria toxin that is an integral part of several approved polysaccharide-conjugate vaccines against encapsulated pathogenic bacteria. CRM197 is a high-value protein needed as a carrier protein in enormous quantities for the manufacturing of conjugate vaccines, which are critical components of global immunisation programs, with billions of doses required each year. However, the scarcity of high-yielding clones, along with the inherent difficulties of soluble protein production and purification, necessitates the intercession of an efficient bioprocess to meet this gap. In the current investigation, we designed a codon-optimized gene construct (named pET30a_crm197) and generated a clone in the E. coli-SHuffle T7 strain that expressed a very high quantity of tag-free soluble recombinant CRM197 protein. With the use of this E. coli clone, a robust inventive fermentation process was designed and carried out, producing a remarkable yield of soluble recombinant CRM197 (up to about 1500 mg/L). Controlled fermentation conditions and rational tweaking to the culture media's carbon, nitrogen, and trace elements were part of the process of optimizing protein expression. Subsequently, an interpreted, rapid, and high-efficiency protein purification process was developed, which uses tangential-flow filtration (TFF) followed by single-step ion-exchange chromatography to produce bioactive and appropriately folded CRM197 protein of high purity. The physicochemical and functional properties of purified CRM197 were determined using various analytical techniques, which confirmed the protein's identity, purity, stability, bioactivity, and secondary structure. This overall work offers vaccine developers a cost-effective, scalable, and integrated bioprocess for high-yield soluble production and purification of rCRM197 carrier protein.</mods:abstract><mods:classification authority="lcc">QR Microbiology</mods:classification><mods:originInfo><mods:dateIssued encoding="iso8061">2026-01</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Elsevier BV</mods:publisher></mods:originInfo><mods:genre>Article</mods:genre></mets:xmlData></mets:mdWrap></mets:dmdSec><mets:amdSec ID="TMD_eprint_3486"><mets:rightsMD ID="rights_eprint_3486_mods"><mets:mdWrap MDTYPE="MODS"><mets:xmlData><mods:useAndReproduction>
<p xmlns="http://www.w3.org/1999/xhtml"><strong>For work being deposited by its own author:</strong> 
In self-archiving this collection of files and associated bibliographic 
metadata, I grant open the right to store 
them and to make them permanently available publicly for free on-line. 
I declare that this material is my own intellectual property and I 
understand that open does not assume any 
responsibility if there is any breach of copyright in distributing these 
files or metadata. (All authors are urged to prominently assert their 
copyright on the title page of their work.)</p>

<p xmlns="http://www.w3.org/1999/xhtml"><strong>For work being deposited by someone other than its 
author:</strong> I hereby declare that the collection of files and 
associated bibliographic metadata that I am archiving at 
open) is in the public domain. If this is 
not the case, I accept full responsibility for any breach of copyright 
that distributing these files or metadata may entail.</p>

<p xmlns="http://www.w3.org/1999/xhtml">Clicking on the deposit button indicates your agreement to these 
terms.</p>
    </mods:useAndReproduction></mets:xmlData></mets:mdWrap></mets:rightsMD></mets:amdSec><mets:fileSec><mets:fileGrp USE="reference"><mets:file ID="eprint_3486_5782_1" SIZE="3018" OWNERID="http://crdd.osdd.net/open/3486/1/references%20%286%29.bib" MIMETYPE="text/x-bibtex"><mets:FLocat LOCTYPE="URL" xlink:type="simple" xlink:href="http://crdd.osdd.net/open/3486/1/references%20%286%29.bib"></mets:FLocat></mets:file></mets:fileGrp></mets:fileSec><mets:structMap><mets:div DMDID="DMD_eprint_3486_mods" ADMID="TMD_eprint_3486"><mets:fptr FILEID="eprint_3486_document_5782_1"></mets:fptr></mets:div></mets:structMap></mets:mets>